Skip to main content
. 2024 Jul 24;84(21):3574–3588. doi: 10.1158/0008-5472.CAN-23-3074

Figure 8.

Figure 8.

Overall schematic presentation of the YAP1–FOXP4–SOX12 axis in gastric cancer. YAP1 directly regulates FOXP4 expression via binding its promoter. FOXP4 exerts oncogenic properties by upregulating SOX12. As a novel therapeutic target, depleting FOXP4 suppresses cancer cell stemness, reverses drug resistance, and reduces peritoneal metastasis. Small molecule targeting FOXP4 quenches YAP1-driven gastric tumor progression and enhances the 5-FU efficacy. (Created with BioRender.com.)